Telum Therapeutics has joined the Treedom platform, which is part of the B corp community, to help create sustainable agroforestry ecosystems and fight climate change.
Telum Therapeutics has become a member of the Spanish Bioindustry Association (Asebio), which strategically promotes the Spanish biotechnology sector and includes more than 300 companies,
In the age of antibiotic resistance, new strategies are needed to treat bacterial infections. In this scenario, bacteriophages, viruses able to infect and kill bacteria,
Antimicrobial resistance (AMR) poses a significant threat to the health of all humankind, with potentially devastating economic consequences. In 2015, the World Health Organization (WHO)
Telum Therapeutics announced today the appointment of Professor Vincent A. Fischetti, that has introduced phage lysins as a new antimicrobial therapy and an alternative to
The concentrations of antibiotic residues found in wastewater and wastewater treatment plants of the WHO Western Pacific region (WPR) and the South-East Asia region (SEAR)
Pamplona, Spain, December 7th 2022.- Telum Therapeutics announced today that Mr. Daniel Couto has been designated to its Board of Directors as an independent director.
Founded in 1868, H.C. Wainwright & Co. is one of the US oldest and most trusted financial institutions. Committed to linking public and private growth
Endolysins are the future against antibiotic-resistant bacteria. These enzymes, produced by bacteriophage viruses, kill bacteria by degrading the peptidoglycan layer that forms the cell wall.
